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Mushrooms are nutritionally functional food and a source of physiologically 
beneficial and nontoxic medicines for various diseased conditions. In the present study 
antimicrobial properties of crude extracts of three commercial edible mushrooms (Agaricus 
bisporus (J.E.Lange) Imbach , Pleurotus florida (Mont.) and Calocybe indica (P&A) were 
tested against bacteria and fungi that cause local dermatitis by disc diffusion method. 
Highest anti-microbial activity was obtained from petroleum ether extract of Agaricus 
bisporus, with the zone of inhibition 17mm (Streptococus pyogenes), 15mm (Staphylococus 
aureus), 14mm (Pseudomonas aeuroginosa) and 13mm (Candida albicans) from 100µg/ml 
concentration of mushroom extracts respectively, while minimal zone was obtained from the 
petroleum ether extract of Pleurotus florida and very least inhibition was observed in 
Calocybe indica. From the results it is inferred that crude extracts of commercially available 
mushrooms namely Agaricus bisporus and Pleurotus florida can be used to treat pathogenic 
microbes that cause skin irritations, bristles and acnes. This study gives scope for the 
investigations on active constituents of mushrooms for better understanding of the healing 
mechanism. 
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Skin, hair, nail, and subcutaneous 
tissues in human are subjected to infection of 
bacteria and fungi that cause dermatitis, acne 
and skin irritations. These diseases are 
widely prevalent all over the world in 
various degrees and are treated with 
antibiotics. The number of multi-drug 
resistant microbial strains and the 
appearance of strains with reduced 
susceptibility to antibiotics are continuously 
increasing. Therefore, there is need to search 
for new infection-fighting strategies to 
control microbial infections (Sieradzki et al., 
1999). Natural products most likely continue 
to exist and grow to become even more 
valuable as sources of new drug leads as they 
have a broader degree of chemical diversity 
and novelty of molecules found in natural 
products (Sai devi et al., 2012). There is a 
renewed interest in traditional medicine and 
an increasing demand for more drugs from 
plant sources. This revival of interest in 
plant-derived drugs is mainly due to the 
current widespread belief that “green 
medicine” is safe and more dependable than 
the costly synthetic drugs, many of which 
have adverse side effects (Nair and Chanda, 
2007). This situation provided the impetus to 
the search for new antimicrobial substances 
from various sources like medicinal plants 
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and fungi including mushrooms (Cordell, 
2000).  
Mushrooms are being used 
nutritionally functional food as well as source 
of physiologically beneficial medicine. The 
use of mushrooms as a source for relief from 
illness can be traced back over five millennia 
to written documents of the early civilization 
in China, Korea and North East, but it is 
doubtless an art as old as mankind. 
Mushrooms represent a rich source of 
antimicrobial agents. The potential of 
mushrooms as source for new drugs is still 
largely unexplored. Among the estimated 
140,000 mushroom species, only small 
percentages have been investigated for their 
therapeutic property and only very few are 
submitted to biological or pharmacological 
screening (Wasser, 2002). In recent years, a 
number of studies have been conducted in 
various countries to prove such efficiency. 
Many mushrooms have been used because of 
their antimicrobial traits, due to their 
secondary metabolites. These products are 
known by their active substances like, 
phenolic compounds which are part of the 
essential oils. Research has shown that some 
mushrooms exhibit in vitro anti-viral, anti-
bacterial, and anti-fungal properties 
(Sorimachi et al., 2001). 
In the present investigation edible 
mushrooms viz, Pleurotus florida, Calocybe 
indica and Agaricus bisporus were tested for 
their remedial activity against microbial 
pathogens that cause various skin infections.  
 
Materials and Methods 
Collection and Extraction of Mushroom 
fruit bodies 
Fresh fruit bodies of Pleurotus florida, 
Calocybe indica and Agaricus bisporus were 
collected from mushroom retail shops and 
farms near Chinnalapatti, Dindigul, Tamil 
Nadu. The fruit bodies were washed 
thoroughly 2-3 times with running water and 
finally with sterile distilled water. Water was 
removed by blotting the mushrooms with 
tissue paper and then they were dried in 
shade, and blended to form a fine powder 
and stored in airtight containers in 
refrigerator at 4°C for future use.  Before 
extraction the stored mushroom powder was 
kept in oven at 55°C for 1hr to remove 
moisture.  
10g of fine powder of each mushroom 
was taken separately in 100 ml of petroleum 
ether in a soxhlet apparatus and extracted for 
8 hrs at 40⁰C.  The aqueous solutions were 
then filtered using Whatman filter paper (No 
1), concentrated in vaccum for 15 min at 37°C 
using a rotary evaporator. The concentrate 
was then dissolved in 5 ml of dimethyl -
sulfoxide (DMSO) and stored at 4°C for 
further study (Nuran and Olcay, 2012). 
 
Test Organism 
Three bacteria (Pseudomonas 
aueroginosa, Staphylococcus aureus and 
Streptococcus pyogenes) and one yeast (Candida 
albicans) were used as pathogenic organisms 
in this study. Microorganisms were procured 
from MTCC, Chandigarh. The bacteria were 
maintained on nutrient broth (NB) at 37°C 
and fungus was maintained on Potato 
dextrose agar (PDA) at 28°C.Fresh 24hr old 
culture of bacteria and 5-8 day old culture of 
fungi were used as an inoculum. 
 
Antibacterial Activity 
The antibacterial activity was tested 
by the disc diffusion method (Anonymous, 
1996) 100µg concentration of three mushroom 
samples dissolved in DMSO were used for 
preparing sterile discs. 10µl (10 cells/ml) of 
24h culture of bacteria grown in nutrient 
broth were seeded into Muller –Hinton Agar 
medium by spread plate method. After 
solidification the filter paper discs (5 mm in 
diameter) impregnated with the extracts were 
placed on test organism seeded plates. 
Streptomycin sulphate (10 µg ml) used as 
positive control and DMSO (100 µg /ml) was 
used as negative control. The antibacterial 
assay plates were incubated at 37°C for 24h. 
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S.aureus and C. albicans. This was in 
accordance with the present results. The 
antimicrobial activity of Pleurotus eryngii and 
Agrocybe sp. varieties showed activity against 
B. megaterium, K. pneumoniae S. aureus and 
C.albicans (Uzun et al., 2004). The broad 
spectrum of antimicrobial activity may be 
attributed to the presence of bioactive 
metabolites of various chemical types in 
mushrooms compounds. The antibacterial of 
the mushrooms might be due to their 
phytochemicals. Govindarajan et al (2006) 
also stated that mushroom species possess 
different constituents in different 
concentration, which account for their 
differential antimicrobial effect.  
Selected pathogens cause a variety of 
suppurative infections in humans like 
superficial skin lesions and irritations and 
when untreated, will lead to more serious 
infections such as pneumonia, meningitis,  
urinary tract infections, food poisoning by 
releasing enterotoxins into food and toxic 
shock syndrome by release of super antigens 
into the blood stream (Lodhia et al., 2009). 
Results of the in vitro study revealed that the 
petroleum ether extract of mushrooms viz, 
P.florida, A.bisporus and C.indica exhibited 
significant inhibitory activity against 
pathogenic bacteria and fungi causing skin 
infection. 
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